(Sharecast News) - Optibiotix Health revealed on Thursday that finance director David Blain had acquired 84,053 ordinary shares in the AIM-listed life sciences business.
Blain, who was appointed to the board of Optiobiotix in January, purchased the shares on Wednesday at an average price of 1,175p, for a total value of...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE